Product Description
Bronchogen is a synthetic short-chain peptide bioregulator engineered specifically to target, repair, and maintain the tissues of the respiratory system. Developed within the framework of Khavinson Peptide research, Bronchogen is a tetrapeptide consisting of four amino acids with the sequence Alanine-Glutamic Acid-Aspartic Acid-Leucine (Ala-Glu-Asp-Leu, or AEDL). It is heavily researched for its organ-specific affinity for the lungs and bronchial epithelium.
Product benefits
Targeted Bronchial Epithelial Repair: Bronchogen exhibits a powerful, tissue-specific affinity for the respiratory system. In pre-clinical testing, it directly regulates the differentiation of bronchial epithelial cells, actively reversing pathological tissue remodeling like goblet cell overgrowth and restoring healthy, functional ciliated cells.
Profound Anti-Inflammatory Action: It operates as a potent regulator of the pulmonary inflammatory response. Bronchogen helps calm chronic, destructive neutrophilic inflammation in the bronchoalveolar space, reducing the production of pro-inflammatory cytokines and protecting airway architecture.
Enhanced Local Mucosal Immunity: Bronchogen significantly boosts local respiratory defenses by stimulating the production of secretory Immunoglobulin A (sIgA). This action reinforces the mucosal barrier, enhancing the lung’s natural ability to withstand external pathogens and environmental irritants.
Optimized Lung Function & Capacity: It stimulates the expression of surfactant protein B, a critical component required to manage alveolar surface tension. By supporting surfactant production, Bronchogen helps maintain healthy airway elasticity, prevents alveolar collapse, and optimizes overall lung capacity.
Epigenetic Respiratory Rejuvenation: Operating as a precise short-chain bioregulator, Bronchogen binds site-specifically to genomic DNA within respiratory tissues. This interaction reactivates dormant or age-silenced genes, effectively restoring youthful protein synthesis and cellular metabolism in aging lungs.